Michael Salomon
Corporate Officer/Principal bij SIRION Biotech GmbH
Profiel
Michael Salomon is currently the Senior Vice President-Development at SIRION Biotech GmbH since 2007.
Prior to this, he worked as the Leader-Research Group at Ludwig-Maximilians-Universität München and as the Head-Research & Development at Vertis Biotechnologie AG.
He obtained his doctorate degree from Ludwig-Maximilians-Universität München in 1991.
Actieve functies van Michael Salomon
| Bedrijven | Functie | Begin |
|---|---|---|
SIRION Biotech GmbH
 SIRION Biotech GmbH Miscellaneous Commercial ServicesCommercial Services SIRION BIOTECH GmbH operates cell modeling and viral vector platforms. The firm offers gene knockdown cells, cell line development, RNA validation services, AV cloning and purification, transduction enhancer and premade adenovirus. The company was founded by Lars Behrend and Christian Thirion in 2006 and is headquartered in Martinsried, Germany. | Corporate Officer/Principal | 01-09-2007 |
Eerdere bekende functies van Michael Salomon
| Bedrijven | Functie | Einde |
|---|---|---|
| Vertis Biotechnologie AG | Hoofd Techniek/Wetenschap/O&O | - |
| Ludwig-Maximilians-Universität München | Corporate Officer/Principal | - |
Opleiding van Michael Salomon
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
SIRION Biotech GmbH
SIRION Biotech GmbH Miscellaneous Commercial ServicesCommercial Services SIRION BIOTECH GmbH operates cell modeling and viral vector platforms. The firm offers gene knockdown cells, cell line development, RNA validation services, AV cloning and purification, transduction enhancer and premade adenovirus. The company was founded by Lars Behrend and Christian Thirion in 2006 and is headquartered in Martinsried, Germany. | Commercial Services |
| Vertis Biotechnologie AG |
